×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
Ovarian Carcinoma
0.500
GeneticVariation
BEFREE
96 of the ovarian carcinoma cases had been previously examined for mutations in TP53 and/or for overexpression of the TP53 protein.
9038623
1996
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
Ovarian Carcinoma
0.500
GeneticVariation
BEFREE
Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
10880552
2000
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
Ovarian Carcinoma
0.500
GeneticVariation
BEFREE
Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53 .
10880552
2000
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Ovarian Carcinoma
0.400
Biomarker
BEFREE
HER-2/neu is a proto-oncogene associated with poor prognosis in women with breast and ovarian carcinoma .
10202671
1999
×
Entrez Id:
596
Gene Symbol:
BCL2
BCL2
Ovarian Carcinoma
0.050
AlteredExpression
BEFREE
BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma .
10646901
2000
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
Ovarian Carcinoma
0.500
GeneticVariation
BEFREE
BRCA2 mutations were less common than BRCA1 mutations in families with any history of ovarian carcinoma .
10717622
2000
LOC111589215
Ovarian Carcinoma
0.010
PosttranslationalModification
BEFREE
BRCA1 promoter region hypermethylation in ovarian carcinoma : a population-based study.
11034065
2000
×
Entrez Id:
1440
Gene Symbol:
CSF3
CSF3
Ovarian Carcinoma
0.020
AlteredExpression
BEFREE
Granulocyte colony-stimulating factor (G-CSF) receptor gene expression of ovarian carcinoma does not correlate with G-CSF caused cell proliferation.
11283939
2001
×
Entrez Id:
29103
Gene Symbol:
DNAJC15
DNAJC15
Ovarian Carcinoma
0.010
Biomarker
BEFREE
MCJ expression was associated with enhanced sensitivity to paclitaxel, topotecan, and cisplatin, suggesting that MCJ loss may play a role in de novo chemoresistance in ovarian carcinoma .
11358853
2001
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
Ovarian Carcinoma
0.500
Biomarker
BEFREE
BRCA1 is a tumor suppressor gene that is responsible for hereditary breast and ovarian carcinoma syndrome.
11443609
2001
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
Ovarian Carcinoma
0.500
Biomarker
BEFREE
BRCA-1 and BRCA-2 are tumor suppressor genes in familial breast-ovarian carcinoma syndrome.
11550149
2001
×
Entrez Id:
3586
Gene Symbol:
IL10
IL10
Ovarian Carcinoma
0.040
Biomarker
BEFREE
Interleukin-10 in serous ovarian carcinoma cell lines.
11570587
2001
×
Entrez Id:
857
Gene Symbol:
CAV1
CAV1
Ovarian Carcinoma
0.030
AlteredExpression
BEFREE
Caveolin-1 expression in ovarian carcinoma is MDR1 independent.
11863219
2002
×
Entrez Id:
6416
Gene Symbol:
MAP2K4
MAP2K4
Ovarian Carcinoma
0.010
Biomarker
BEFREE
Mitogen-activated protein kinase kinase 4 (MKK4 ) acts as a metastasis suppressor gene in human ovarian carcinoma .
12438272
2002
×
Entrez Id:
94025
Gene Symbol:
MUC16
MUC16
Ovarian Carcinoma
0.100
Biomarker
BEFREE
CA125 and UQCRFS1 FISH studies of ovarian carcinoma .
12821338
2003
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Ovarian Carcinoma
0.070
AlteredExpression
BEFREE
COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
14719060
2004
×
Entrez Id:
107075310
Gene Symbol:
MTCO2P12
MTCO2P12
Ovarian Carcinoma
0.040
AlteredExpression
BEFREE
COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
14719060
2004
×
Entrez Id:
4513
Gene Symbol:
COX2
COX2
Ovarian Carcinoma
0.040
AlteredExpression
BEFREE
COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
14719060
2004
×
Entrez Id:
94025
Gene Symbol:
MUC16
MUC16
Ovarian Carcinoma
0.100
Biomarker
BEFREE
CA 125 is the most reliable serum marker for ovarian carcinoma .
14739059
2004
×
Entrez Id:
1440
Gene Symbol:
CSF3
CSF3
Ovarian Carcinoma
0.020
AlteredExpression
BEFREE
Granulocyte colony-stimulating factor suppresses autologous tumor killing activity of the peripheral blood lymphocytes in the patients with ovarian carcinoma .
15214947
2004
×
Entrez Id:
2118
Gene Symbol:
ETV4
ETV4
Ovarian Carcinoma
0.010
AlteredExpression
BEFREE
PEA3 mRNA expression was comparable at all sites in ovarian carcinoma (44 out of 83; 53% of effusions, 48 out of 102; 47% of solid tumors).
15387369
2004
×
Entrez Id:
596
Gene Symbol:
BCL2
BCL2
Ovarian Carcinoma
0.050
AlteredExpression
BEFREE
Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma .
15505422
2004
×
Entrez Id:
1801
Gene Symbol:
DPH1
DPH1
Ovarian Carcinoma
0.010
Biomarker
BEFREE
OVCA1 , also known as DPH2L1 , is a tumor suppressor gene associated with ovarian carcinoma and other tumors.
15661533
2005
×
Entrez Id:
6690
Gene Symbol:
SPINK1
SPINK1
Ovarian Carcinoma
0.010
Biomarker
BEFREE
Tumor-associated trypsin inhibitor (TATI ) is a marker of mucinous ovarian carcinoma , but it is also widely expressed in other malignant tumors and normal human tissues.
16327984
2006
×
Entrez Id:
79679
Gene Symbol:
VTCN1
VTCN1
Ovarian Carcinoma
0.010
AlteredExpression
BEFREE
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma .
16606666
2006